Jinyu Bio-Technology Co.,Ltd. — Investor Relations & Filings
About Jinyu Bio-Technology Co.,Ltd.
Jinyu Bio-Technology Co., Ltd. focuses on the research, development, and manufacturing of veterinary biological products and pharmaceuticals. The company is a prominent supplier of animal vaccines, particularly specializing in Foot-and-Mouth Disease (FMD) vaccines, brucellosis vaccines, and solutions for swine and poultry diseases. It utilizes advanced biotechnology platforms, including large-scale suspension culture and high-efficiency purification processes, to produce high-titer, high-purity biologicals. The organization operates sophisticated research facilities and Biosafety Level 3 (P3) laboratories to support the development of diagnostic reagents and preventive treatments. Its operations center on enhancing animal health through scientific innovation, providing comprehensive disease control strategies for the global livestock industry and large-scale agricultural operations.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 金宇生物技术股份有限公司2024年年度报告摘要 | 2025-04-24 | Chinese | |
| 金宇生物技术股份有限公司董事会审计委员会对会计师事务所2024年度履行监督职责情况报告 | 2025-04-24 | Chinese | |
| 金宇生物技术股份有限公司2024年年度利润分配方案公告 | 2025-04-24 | Chinese | |
| 金宇生物技术股份有限公司董事会议事规则（2025年4修订） | 2025-04-24 | Chinese | |
| 金宇生物技术股份有限公司2024年年度内部控制审计报告 | 2025-04-24 | Chinese | |
| 金宇生物技术股份有限公司关于2024年度计提资产减值准备及坏账核销的公告 | 2025-04-24 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 40525742 | 金宇生物技术股份有限公司2024年年度报告摘要 | 2025-04-24 | Chinese | ||
| 40525728 | 金宇生物技术股份有限公司董事会审计委员会对会计师事务所2024年度履行监督职责情况报告 | 2025-04-24 | Chinese | ||
| 40525715 | 金宇生物技术股份有限公司2024年年度利润分配方案公告 | 2025-04-24 | Chinese | ||
| 40525706 | 金宇生物技术股份有限公司董事会议事规则（2025年4修订） | 2025-04-24 | Chinese | ||
| 40525695 | 金宇生物技术股份有限公司2024年年度内部控制审计报告 | 2025-04-24 | Chinese | ||
| 40525670 | 金宇生物技术股份有限公司关于2024年度计提资产减值准备及坏账核销的公告 | 2025-04-24 | Chinese | ||
| 40525658 | 金宇生物技术股份有限公司关于使用闲置自有资金进行现金管理的公告 | 2025-04-24 | Chinese | ||
| 40525648 | 金宇生物技术股份有限公司关于2023年员工持股计划第二个锁定期解锁条件未成就及回购注销部分股票的公告 | 2025-04-24 | Chinese | ||
| 40525636 | 金宇生物技术股份有限公司2024年度可持续发展报告 | 2025-04-24 | Chinese | ||
| 40525238 | 金宇生物技术股份有限公司董事会关于对独立董事独立性自查情况的专项意见 | 2025-04-24 | Chinese | ||
| 40525227 | 金宇生物技术股份有限公司2024年度独立董事述职报告（吴振平） | 2025-04-24 | Chinese | ||
| 40525214 | 独立董事候选人声明与承诺-德力格尔巴图 | 2025-04-24 | Chinese | ||
| 40525200 | 独立董事候选人声明与承诺-吴振平 | 2025-04-24 | Chinese | ||
| 40525152 | 金宇生物技术股份有限公司关于选举职工董事的公告 | 2025-04-24 | Chinese | ||
| 40525142 | 金宇生物技术股份有限公司2024年非经营性资金占用及其他关联资金往来情况 | 2025-04-24 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Jinyu Bio-Technology Co.,Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/56561/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=56561 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=56561 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=56561 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 56561}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Jinyu Bio-Technology Co.,Ltd. (id: 56561)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.